Phase 2 Study of the Assessment of Pulmonary Function, Safety, Tolerability, and PK of Zileuton Injection in Patients With Chronic Stable Asthma

Trial Profile

Phase 2 Study of the Assessment of Pulmonary Function, Safety, Tolerability, and PK of Zileuton Injection in Patients With Chronic Stable Asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2008

At a glance

  • Drugs Zileuton (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Critical Therapeutics
  • Most Recent Events

    • 03 Jun 2008 Top-line results reported in a Critical Therapeutics media release.
    • 20 Mar 2008 Status change from in progress to completed.
    • 09 Jan 2008 Status change from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top